Medical Device Network on MSN
BD and Ypsomed develop new version of Neopak XtraFlow syringe
The new 5.5ml BD Neopak XtraFlow Syringe uses BD’s advanced technologies, including thinner cannulas.
Zacks Investment Research on MSN
BD and Ypsomed expand partnership to target growing biologics market
Becton, Dickinson and Company BDX, popularly known as BD, recently announced the expansion of its partnership with Ypsomed to ...
Amid constant drug shortages exacerbated by weak links in the supply chain, medical glass maker Schott Pharma is looking to fill the cracks with a new $371 million North Carolina facility. Along with ...
(MENAFN- Comserve) Shibuya-ku, Tokyo, Japan, Japan, Aug 24, 2021, 09:30 /Comserve / -- Glass Syringe Market :Global Size, Share Report,Market Trends, Industry ...
After EUR 76 million (HUF 28,044 billion) investment and 1.5 years of construction, SCHOTT Pharma opens its newest production facility in Lukácsháza, Hungary Expanding production capacity will support ...
BD announced the launch of BD Neopak 2.25mL prefillable glass syringes intended for biopharmaceutical manufacturers that handle high-value and sensitive biologic agents that require higher quality ...
The 5.5mL version of the BD Neopak XtraFlow syringe is fully compatible with Ypsomed’s YpsoMate 5.5 autoinjector platform.
Glass Prefilled Syringe Market 2022 with Size, Status, and Development Strategy Pre and Post COVID-19, by Corporate Strategy Analysis, Landscape, Type, Application, and Prominent Countries till 2030 ...
EQS-News: SCHOTT Pharma AG & Co. KGaA / Key word(s): Expansion Expanding prefillable glass syringe output: SCHOTT Pharma opens state-of-the-art production facility in Lukácsháza, Hungary 14.06.2024 / ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results